“Although the [c]ourt finds [p]laintiff arguments for civil contempt compelling, [d]efendants have now come into compliance, thus rendering it unnecessary for the [c]ourt to address sanctions and attorneys’ fees,” wrote U.S. District Judge Raymond A. Jackson of the Eastern District of Virginia. “Further, [d]efendants provided a good-faith defense for delaying compliance with the [c]ourt’s [o]rder. […]

“These are fairly uncharted waters,” Judge Stephen Dillard said of a case that explores a jury award in a case where there was no award for pain and suffering or medical costs.        

The average annual growth in income partner classes at some of the most profitable firms between 2017 and 2022 was 13.4%, while at other large, two-tier partner firms, it was 4%, according to a report this week.        

Did the 2018 Farm Bill preempt states from regulating hemp-synthesized intoxicants? Federal courts have offered two different answers so far.        

“Our client spent over $100,000 to purchase a brand-new, custom top-of-the-line Jeep, and received a vehicle that was dirty, damaged and used. We are pleased that the Court rejected the manufacturer’s attempt to avoid liability for its deceptive conduct, and look forward to putting our case to the jury,” said Berezin’s attorney, Yitzchak Zelman of […]

Tracking Key Shifts in the Legal Ecosystem Each week, the Law.com Barometer newsletter, powered by the ALM Global Newsroom and Legalweek brings        

“I’ve been doing this a long time, and we’re used to cycles in all directions. But this is a very unique time in the world, and I think it’s a mistake to forget all of the uncertainty that exists,” said Richard Rosenbaum, executive chairman of Greenberg Traurig.        

The news and analysis you need to start your day.        

It was the FTC that garnered headlines earlier this year by updating its guidance for social media endorsements. But states are getting in on the enforcement action, emboldened by consumer protection laws on their books.        

U.S. District Judge Brian Cogan will oversee the lawsuits, brought against more than 20 companies that make or sell oral decongestants containing phenylephrine.